Invo BioScience ROA 2010-2024 | NAYA
Current and historical return on assets (ROA) values for Invo BioScience (NAYA) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Invo BioScience ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2024-06-30 |
$-0.01B |
$0.02B |
-36.84% |
| 2024-03-31 |
$-0.01B |
$0.02B |
-43.08% |
| 2023-12-31 |
$-0.01B |
$0.02B |
-60.38% |
| 2023-09-30 |
$-0.01B |
$0.02B |
-100.00% |
| 2023-06-30 |
$-0.01B |
$0.01B |
-200.00% |
| 2023-03-31 |
$-0.01B |
$0.01B |
-228.57% |
| 2022-12-31 |
$-0.01B |
$0.00B |
-200.00% |
| 2022-09-30 |
$-0.01B |
$0.01B |
-120.00% |
| 2022-06-30 |
$-0.01B |
$0.01B |
-96.97% |
| 2022-03-31 |
$-0.01B |
$0.01B |
-75.68% |
| 2021-12-31 |
$-0.01B |
$0.01B |
-63.16% |
| 2021-09-30 |
$-0.01B |
$0.01B |
-102.56% |
| 2021-06-30 |
$-0.01B |
$0.01B |
-121.21% |
| 2021-03-31 |
$-0.01B |
$0.01B |
-144.00% |
| 2020-12-31 |
$-0.01B |
$0.01B |
-200.00% |
| 2020-09-30 |
$-0.01B |
$0.00B |
-285.71% |
| 2020-06-30 |
$-0.00B |
$0.00B |
-200.00% |
| 2020-03-31 |
$-0.00B |
$0.00B |
-133.33% |
| 2019-12-31 |
$-0.00B |
$0.00B |
-66.67% |
| 2019-09-30 |
$-0.00B |
$0.00B |
-72.73% |
| 2019-06-30 |
$-0.00B |
$0.00B |
-44.44% |
| 2019-03-31 |
$-0.00B |
$0.00B |
-171.43% |
| 2018-12-31 |
$-0.00B |
$0.00B |
-400.00% |
| 2018-09-30 |
$-0.00B |
$0.00B |
-400.00% |
| 2018-06-30 |
$-0.00B |
$0.00B |
-800.00% |
| 2018-03-31 |
$0.00B |
$0.00B |
nan% |
| 2017-12-31 |
$0.00B |
$0.00B |
nan% |
| 2017-09-30 |
$0.00B |
$0.00B |
nan% |
| 2017-06-30 |
$0.00B |
$0.00B |
nan% |
| 2017-03-31 |
$-0.00B |
$0.00B |
inf% |
| 2016-12-31 |
$-0.00B |
$0.00B |
-400.00% |
| 2016-09-30 |
$-0.00B |
$0.00B |
-200.00% |
| 2016-06-30 |
$-0.00B |
$0.00B |
-200.00% |
| 2016-03-31 |
$-0.00B |
$0.00B |
-800.00% |
| 2015-12-31 |
$-0.00B |
$0.00B |
-1600.00% |
| 2015-09-30 |
$-0.00B |
$0.00B |
inf% |
| 2015-06-30 |
$-0.00B |
$0.00B |
inf% |
| 2015-03-31 |
$0.00B |
$0.00B |
nan% |
| 2011-12-31 |
$0.00B |
$0.00B |
nan% |
| 2011-09-30 |
$0.00B |
$0.00B |
nan% |
| 2011-06-30 |
$0.00B |
$0.00B |
nan% |
| 2011-03-31 |
$0.00B |
$0.00B |
nan% |
| 2010-12-31 |
$0.00B |
$0.00B |
inf% |
| 2010-09-30 |
$0.00B |
$0.00B |
inf% |
| 2010-06-30 |
$-0.00B |
$0.00B |
inf% |
| 2010-03-31 |
$-0.00B |
$0.00B |
inf% |
| 2009-12-31 |
$-0.00B |
$0.00B |
inf% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.004B |
$0.003B |
|
INVO Bioscience is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. It engages in the development and manufacture of its lead product, INVOcell, a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. INVO Bioscience focuses on selling its product to IVF centers and physicians through distributors, as well as directly to physicians in Europe, Canada, Latin America, and the Middle East.
|
